Physician profile
Patrick J Byrne
NPI 1396703591
$3,433.55
in general payments reported to CMS, 2019-2025
17 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2021: $1,029 · 2022: $478 · 2023: $374 · 2024: $425 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $750.00 | 2021 | |
| Stryker Corporation | $422.25 | 2019-2023 | Vsp System, Vsp Cranial, Na |
| Checkpoint Surgical, INC | $316.61 | 2019-2023 | Checkpoint Stimulators |
| Depuy Synthes Sales INC. | $265.13 | 2019-2022 | |
| Medical Device Business Services, INC. | $208.32 | 2019 | |
| Integra Lifesciences Corporation | $169.52 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Intersect Ent, INC. | $148.49 | 2021 | |
| Smith+Nephew, INC. | $146.67 | 2024 | Ent Sinus |
| Aroa Biosurgery Incorporated | $145.76 | 2025 | |
| Tactile Systems Technology INC | $144.17 | 2022 | |
| Merz Pharmaceuticals, LLC | $142.68 | 2024 | Xeomin |
| Sientra, INC. | $141.35 | 2022 | |
| Acera Surgical, INC. | $137.66 | 2025 | Restrata Wound Matrix |
| Galderma Laboratories, L.P. | $110.98 | 2019 | |
| Kls-Martin L.P. | $97.88 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $49.61 | 2023 | Hemoblast Bellows |
| Musculoskeletal Transplant Foundation INC. | $36.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Byrne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.